40 participants
A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-08-02
- Start Date:
- 2024-08-31
- Completion:
- 2026-07-31
Conditions
- Hepatocellular Carcinoma Non-resectable
Interventions
- DRUG
No Results Yet